Guilin Sanjin Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guilin Sanjin Pharmaceutical Co Ltd with three other
companies in this sector in China:
Shandong Shanda Wit Science and Technology Co Ltd
sales of 1.54 billion Chinese Renmimbi [US$244.19 million]
of which 57%
Jinhe Biotechnology Co Ltd
(1.50 billion Chinese Renmimbi [US$236.53 million]
of which 72%
was Medical Feeds Additives), and
Shanghai Kaibao Pharmaceutical Company Limited
(1.50 billion Chinese Renmimbi [US$236.82 million]
of which 100%
Guilin Sanjin Pharmaceutical Co Ltd reported sales of 1.53 billion Chinese Renmimbi (US$241.26 million)
December of 2016.
increase of 11.2%
versus 2015, when the company's sales were 1.37 billion Chinese Renmimbi.
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
120.1% in 2016, from
30.57 million Chinese Renmimbi to 67.29 million Chinese Renmimbi.
Not all segments of Guilin Sanjin Pharmaceutical Co Ltd experienced an increase in sales in 2016:
sales of Commodity Circulation fell 0.1% to 30.05 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).